Certolizumab pegol – new option in the treatment of psoriatic arthritis
It has been proven that tumor necrosis factor (TNF) plays an important role in the pathophysiology of psoriatic arthritis (PsA). TNF inhibitors have been demonstrated to improve the skin and joint manifestations of psoriasis. New possibilities of treatment of the disease have appeared due to availab...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Termedia Publishing House
2014-07-01
|
| Серія: | Rheumatology |
| Предмети: | |
| Онлайн доступ: | http://www.termedia.pl/Certolizumab-pegol-new-option-in-the-treatment-of-psoriatic-arthritis,18,23171,1,1.html |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|